Levels of inflammatory factors such as interleukin 6 (IL-6) and TNF-α are significantly increased in patients with DM, and type 2 DM (T2DM) is classified as a metabolic inflammatory disease [22, 23]. This evidence concerns the gene IL6 and type 2 diabetes mellitus.